Exploring the osteoporosis treatment gap after fragility hip fracture at a Tertiary University Medical Center in Thailand

Completed

• Conditions: Persistence rate of anti-osteoporosis drug treatment in hip fracture patient; Osteoporosis, Hip fracture

• Registration Number: TCTR20210824002
• Lead Sponsor: /A

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2021-06-30
• Study Start: 2021-08-24
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 562

Inclusion Criteria

1. Previous osteoporotic hip fracture patient whom admitted and operated in Siriraj hospital
2. Age 50 years old or more
3. At least 1 year follow-up period

Exclusion Criteria

1.Pathological hip fracture
2.Atypical femoral fracture
3.High energy injury
4.Inability to communicate

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Persistence rate 1 year Prescription of anti-osteoporosis agent

Secondary Outcome Measures

Name	Time	Method
Reason of non-persistence 1 year Reason of discontinuation of anti-osteoporosis agent